/wp-content/uploads/2019/01/UCSD_logo-tansparent-300-1-300x81-no-hosted-300x81.png00Mathew Chvasta/wp-content/uploads/2019/01/UCSD_logo-tansparent-300-1-300x81-no-hosted-300x81.pngMathew Chvasta2022-08-03 19:37:242023-08-03 19:38:13TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma.
